Page 7 - Disease Activity News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Disease activity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Disease Activity Today - Breaking & Trending Today

Temporal Study Finds No Link Between Weight Gain and RA Disease Activity

Researchers assessed the relationship between changes in body mass index and disease activity and radiographic progression among patients with rheumatoid arthritis treated with infliximab. Increasing BMI over time among infliximab-treated patients with RA did not affect disease activity, and was found to have a protective-effect on joint erosions. ....

Swiss Clinical Quality Management , Rheumatic Diseases , Disease Activity ,

Real-World Study Shows JAK Inhibitors Are Effective in Treating Rheumatoid Arthritis

One in 3 people with rheumatoid arthritis taking these JAK inhibitors reach remission, the study showed. ....

United States , Rajat Bhatt , Shinya Hayashi , Kobe University , Memorial Hermann Health System In Richmond , Oxford University , Drug Administration , Oxford University Press , Arthritis Foundation , Impressive Reductions , Disease Activity , University Press , Come With Some Safety , Memorial Hermann Health System ,

Obesity Among Patients With Psoriatic Arthritis Reduces Remission Rates

Researchers assessed whether patients with psoriatic arthritis and comorbid obesity were less likely to achieve remission/low disease activity. Patients with PsA and comorbid obesity are less likely to achieve remission or LDA and have higher pain scores, worse physical function, and worse HR-QOL. ....

Disease Activity , Psoriatic Arthritis , Very Low Disease Activity ,

U.S. FDA Approves Pfizer's VELSIPITY for Adults with Moderately to Severely Active Ulcerative Colitis (UC)

13.10.2023 - Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved VELSIPITY (etrasimod), an oral, once-daily, selective sphingosine-1-phosphate (S1P) receptor modulator for adults with moderately to severely . ....

United States , Angela Hwang , Michael Chiorean , Registrational Program , Exchange Commission , Colitis Foundation , Crohn Colitis Foundation , Center At Swedish Medical , European Medicines Agency , Chief Commercial Officer , Global Biopharmaceuticals Business , Swedish Medical Center , Michael Osso , Marketing Authorization Application , Posterior Reversible Encephalopathy Syndrome , Change Patient , Annual Report , Looking Information , Factors That May Affect Future , Prescription Medicines , Accessed December , Ethnic Distribution , Inflammatory Bowel Disease , Ulcerative Colitis , Inflamm Bowel , Disease Activity ,

Horizon Therapeutics (HZNP) Announces New UPLIZNA (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2023

Horizon Therapeutics (HZNP) Announces New UPLIZNA (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Massimo Filippi , Neuroimmunol Neuroinflamm , Maria Rocca , Orhan Aktas , Jeffrey Bennett , European Commission , Drug Administration , Brazilian Health Regulatory Agency , Research In Multiple Sclerosis , Association Of Cytokine , European Committee For Treatment , Horizon Therapeutics , European Committee , Multiple Sclerosis , Cytokine Proteins , Disease Activity , Receiving Inebilizumab Treatment , Long Term Comparative Efficacy , Open Label Extension Versus Azathioprine , Immunosuppressive Therapies , Versus Placebo , Matching Adjusted Indirect Comparison , Current Treatments , Long Term Effectiveness , Neuromyelitis Optica Spectrum Disorder , Hepatitisb Virus ,